NovoCure Ltd — Director's Dealing 2015

Oct 1, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2015-10-01

Reporting Person: Danziger Asaf (Director, Chief Executive Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	923557	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to Buy Ordinary Shares	$0.17	2016-05-01	Ordinary Shares (59130)		Direct
Options to Buy Ordinary Shares	$0.17	2017-03-28	Ordinary Shares (342954)		Direct
Options to Buy Ordinary Shares	$0.38	2020-10-12	Ordinary Shares (354780)		Direct
Options to Buy Ordinary Shares	$3.44	2021-12-14	Ordinary Shares (446863)		Direct
Options to Buy Ordinary Shares	$7.48	2024-02-26	Ordinary Shares (88695)		Direct
Options to Buy Ordinary Shares	$14.37	2025-02-25	Ordinary Shares (354780)		Direct

Footnotes

F1: Fully vested and currently exercisable as of the date hereof.

F2: Options to buy 335,147 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 111,716 ordinary shares will vest and become exercisable on December 14, 2015, subject to Mr. Danziger's continued employment through such date.

F3: Options to buy 22,173 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 66,522 ordinary shares will vest and become exercisable in equal installments on February 26, 2016, 2017 and 2018 subject to Mr. Danziger's continued employment through such dates.

F4: Options to buy 356,780 ordinary shares will vest and become exercisable in equal installments on each of February 25, 2016, 2017, 2018 and 2019, subject to Mr. Danziger's continued employment through such dates.